Houston, TX, United States of America

Joseph Walter Carpenter

This inventor holds 6 USPTO granted patents. Top assignees: Recursion Pharmaceuticals, Inc., Other. Active years: 2004-2026.


% Patents Active = 83.3

Average Co-Inventor Count = 1.3

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Houston, TX (US) (2020)
  • Las Vegas, NV (US) (2004 - 2023)
  • Bountiful, UT (US) (2024)

Company Filing History:


Years Active: 2004-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Joseph Walter Carpenter: Innovator in Heterocyclic Compounds

Introduction

Joseph Walter Carpenter is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic compounds. With a total of 6 patents to his name, Carpenter's work has the potential to impact various medical treatments.

Latest Patents

Carpenter's latest patents focus on heterocyclic compounds and related methods. These patents provide compounds of Formula (I) and Formula (II), along with their stereoisomers, tautomers, and pharmaceutically acceptable salts or solvates. Additionally, the patents describe pharmaceutical compositions that incorporate these compounds and outline methods for treating diseases, disorders, or conditions using these innovative formulations.

Career Highlights

Throughout his career, Carpenter has worked with various companies, including Recursion Pharmaceuticals, Inc. His expertise in the field has allowed him to contribute to advancements in pharmaceutical research and development.

Collaborations

Carpenter has collaborated with notable individuals in his field, including Carl Brooks and Michael James Genin. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

Joseph Walter Carpenter is a distinguished inventor whose work in heterocyclic compounds has the potential to advance medical treatments. His contributions to the pharmaceutical industry are noteworthy and reflect his commitment to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…